Clinical Trial 49792

Pinellas Park, FL 33782


The purpose of this study is to demonstrate that study drug 1 mg once-weekly improves clinical outcomes including walking distance compared to placebo in patients with type 2 diabetes and intermittent claudication due to peripheral arterial disease (PAD).  The study requires 9 visits over the period of 1 year.  The medication is a weekly injection.  Subjects will be required to walk on a treadmill at a very slow pace.  Subjects will be seen by a board-certified physician and the study nurse.  Compenation will be provided for completed visits.

Qualified Participants Must:

• Be at least 18 years of age
• have controlled Type 2 diabetes
• have pain in the calves when walking that stops at rest
• be willing to attend study visits about once per month for the first 3 months and every three months following
• be able and willing to walk on a treadmill
• must not be taking a GLP-1 receptor antagonist such as Victoza

Qualified Participants May Receive:

All Medical evaluations, study treatment or placebo, monitoring throughout the study and compensation for time and travel

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.